GCM
RVMD icon

Ghisallo Capital Management’s Revolution Medicines RVMD Stock Holding History

Ghisallo Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.36M Buy
+50,000
New +$7.3M 0.18% 98
2025
Q1 		– Sell
-257,100
Closed -$11.2M – 138
2024
Q4 		$11.2M Buy
+257,100
New +$13M 0.65% 31
2023
Q4 		– Sell
-25,000
Closed -$692K – 164
2023
Q3 		$692K Hold
25,000
– – 0.07% 96
2023
Q2 		$669K Hold
25,000
– – 0.08% 101
2023
Q1 		$542K Buy
+25,000
New +$616K 0.13% 55

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Ghisallo Capital Management's RVMD Position: Q2 2026 in Review

Ghisallo Capital Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 50,000 shares worth $9.36M. The stake represents 0.18% of the portfolio and ranks #98 among its holdings. This is a return to the name: Ghisallo Capital Management previously reported a position in RVMD as recently as Q4 2024.

Ghisallo Capital Management first reported a position in RVMD in Q1 2023 and has held it in 5 quarters since. The position peaked at $11.2M in Q4 2024. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Ghisallo Capital Management held 50,000 shares of Revolution Medicines worth $9.36M as of Q2 2026.
  • Revolution Medicines was a new Ghisallo Capital Management position in Q2 2026.
  • Revolution Medicines made up 0.18% of Ghisallo Capital Management's portfolio in Q2 2026, its #98 holding.
  • Ghisallo Capital Management first reported a position in Revolution Medicines in Q1 2023 and has held it in 5 quarters since.
  • Ghisallo Capital Management's Revolution Medicines position peaked at $11.2M in Q4 2024.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.